<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Advanced Cardiovascular & Metabolic Profiling | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
 list-style: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
 border-radius: 12px;
 overflow: hidden;
 box-shadow: 0 4px 15px rgba(0,0,0,0.05);
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 6px solid #722F37;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 list-style: disc;
 margin-left: 20px;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 10px;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 20: L2: Assessment Tools</span>
 <h1 class="lesson-title">Advanced Cardiovascular & Metabolic Profiling</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 7 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üí° Clinical Excellence</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ CFMP‚Ñ¢ Core Curriculum</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#beyond-ldlc"><span class="section-num">01</span>Beyond LDL-C</a></li>
 <li><a href="#vascular-inflammation"><span class="section-num">02</span>Vascular Inflammation</a></li>
 <li><a href="#metabolic-early-warning"><span class="section-num">03</span>Metabolic Early Warning</a></li>
 <li><a href="#fatty-acid-architecture"><span class="section-num">04</span>Fatty Acid Architecture</a></li>
 <li><a href="#targeted-protocols"><span class="section-num">05</span>Targeted Protocols</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>In previous lessons, we explored the gut, hormones, and genomics. Now, we apply the <strong>R.O.O.T.S. Method‚Ñ¢</strong> to the #1 cause of mortality worldwide: cardiovascular disease. We move beyond "standard" panels to identify risk years before a clinical event occurs.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Practitioner. For many of your clients‚Äîespecially women in the perimenopausal transition‚Äîcardiovascular health is a significant concern. Standard lipid panels often provide a false sense of security, as 50% of people hospitalized for a first heart attack have "normal" cholesterol levels. In this lesson, you will master the <strong>advanced biomarkers</strong> that reveal the true state of the vascular and metabolic systems.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the clinical superiority of LDL-P and particle size over standard LDL-C measurements.</li>
 <li>Interpret advanced inflammatory markers (Lp-PLA2, MPO, GlycA) to assess plaque stability.</li>
 <li>Evaluate early-stage insulin resistance using HOMA-IR and Adiponectin/Leptin ratios.</li>
 <li>Utilize the Omega-3 Index to assess cellular membrane health and cardiovascular resilience.</li>
 <li>Design targeted "Target" phase protocols based on advanced profiling results.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
 <div>
 <p class="title">Case Study: The "Healthy" Executive</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 48, Wellness enthusiast.</p>
 <p><strong>Presentation:</strong> Sarah exercises 5 days a week, eats a "clean" diet, and has a standard LDL-C of 110 mg/dL (considered "near optimal"). However, she reports brain fog and stubborn mid-section weight gain.</p>
 <p><strong>Advanced Findings:</strong> Her NMR Lipoprofile revealed an LDL-P of 1,800 nmol/L (High Risk) and a "Pattern B" (small, dense particles). Her HOMA-IR was 3.2, indicating significant subclinical insulin resistance.</p>
 <p><strong>Outcome:</strong> By identifying that Sarah had a <em>high number</em> of <em>small</em> particles and early metabolic dysfunction, the practitioner implemented a lower-carbohydrate, higher-fiber protocol and targeted berberine supplementation. Six months later, her LDL-P dropped to 1,100 nmol/L and her brain fog resolved.</p>
 </div>
 </div>

 <h2 id="beyond-ldlc">Beyond LDL-C: The Particle Revolution</h2>
 <p>In conventional medicine, the focus remains almost exclusively on <strong>LDL-C</strong>, which measures the <em>weight</em> of cholesterol carried in Low-Density Lipoprotein particles. However, functional medicine recognizes that it isn't the weight of the cargo that matters most, but the <span class="highlight">number of vehicles (particles)</span> on the road.</p>

 <p>Think of it this way: If you have 100 pounds of passengers, they could be traveling in 2 large buses (Low Risk) or 50 small motorcycles (High Risk). The motorcycles are much more likely to crash into the arterial wall (the endothelium) and become trapped, leading to plaque formation.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Conventional Interpretation</th>
 <th>Functional Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>LDL-P (Particle Number)</strong></td>
 <td>Often not measured</td>
 <td>The most accurate predictor of cardiovascular risk; target &lt;1000 nmol/L.</td>
 </tr>
 <tr>
 <td><strong>Small Dense LDL</strong></td>
 <td>Ignored</td>
 <td>Highly atherogenic; easily oxidized and small enough to penetrate the endothelium.</td>
 </tr>
 <tr>
 <td><strong>ApoB</strong></td>
 <td>Secondary marker</td>
 <td>A direct measure of the total number of atherogenic particles (LDL, VLDL, IDL).</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>When explaining this to clients, use the "Tennis Ball vs. Golf Ball" analogy. Large, fluffy LDL (Pattern A) are like tennis balls‚Äîthey bounce off the arterial wall. Small, dense LDL (Pattern B) are like golf balls‚Äîthey can get lodged in the "netting" of the arterial lining and cause trouble.</p>
 </div>

 <h2 id="vascular-inflammation">Vascular Inflammation: The Fire Inside</h2>
 <p>Cholesterol is merely the "spackle" the body uses to repair damage. The <em>damage</em> is caused by inflammation. Advanced profiling allows us to look at the "fire" within the vessel walls.</p>

 <ul>
 <li><strong>Lp-PLA2 (PLAC Test):</strong> An enzyme produced by macrophages within the plaque itself. If this is high, it indicates the plaque is "active" and prone to rupture.</li>
 <li><strong>Myeloperoxidase (MPO):</strong> A marker of neutrophil activation and oxidative stress in the artery. High levels suggest the body's "first responders" are attacking the vessel wall.</li>
 <li><strong>GlycA:</strong> A systemic marker of protein glycation and inflammation that is more stable than hs-CRP and highly predictive of long-term risk.</li>
 </ul>

 <p>A 2022 meta-analysis found that individuals with elevated <strong>Lp-PLA2</strong> had a <span class="highlight">2x higher risk</span> of coronary heart disease, even if their cholesterol levels were perfect.</p>

 <h2 id="metabolic-early-warning">Metabolic Early Warning Systems</h2>
 <p>Cardiovascular disease is, at its core, a metabolic disease. By the time fasting blood glucose rises above 100 mg/dL, the body has been struggling for a decade. We use advanced metabolic markers to catch this early.</p>

 <h3>HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)</h3>
 <p>This is a calculation using fasting insulin and fasting glucose. It tells us how hard the pancreas is working to maintain "normal" blood sugar. A HOMA-IR &gt; 1.9 indicates early insulin resistance, even if glucose is "normal" at 85 mg/dL.</p>

 <h3>Adiponectin & Leptin</h3>
 <p><strong>Adiponectin</strong> is a "good" hormone secreted by fat cells that improves insulin sensitivity and protects the heart. <strong>Leptin</strong> is the satiety hormone that becomes elevated in "leptin resistance." A low Adiponectin/Leptin ratio is a powerful indicator of visceral fat (organ fat) and metabolic inflammation.</p>

 <div class="coach-tip">
 <span class="tip-label">Income Opportunity</span>
 <p>Many practitioners offer a "Cardiometabolic Deep Dive" package. By bundling these advanced tests with two 45-minute interpretation sessions, practitioners like you are commanding fees of $750‚Äì$1,200 per client, providing a level of preventative care that standard insurance-based models simply cannot match.</p>
 </div>

 <h2 id="fatty-acid-architecture">Fatty Acid Architecture & The Omega-3 Index</h2>
 <p>The health of every cell membrane in the body determines cardiovascular resilience. The <strong>Omega-3 Index</strong> measures the percentage of EPA and DHA in red blood cell membranes.</p>
 
 <p>Research indicates that an Omega-3 Index of <strong>&gt;8%</strong> is associated with the lowest risk of sudden cardiac death, whereas an index of &lt;4% represents the highest risk. Most Americans eating a standard diet hover around 3-5%.</p>

 <h2 id="targeted-protocols">Clinical Application: Targeted Protocols</h2>
 <p>Once the "Reveal" phase (testing) is complete, we move to the <strong>Target</strong> phase of the R.O.O.T.S. Method‚Ñ¢.</p>

 <ul>
 <li><strong>If LDL-P is high + Small Dense:</strong> Prioritize carbohydrate restriction, increased soluble fiber (glucomannan), and consider Bergamot or Red Yeast Rice (with CoQ10).</li>
 <li><strong>If Lp-PLA2 is high:</strong> Focus on intense antioxidant support (Curcumin, Resveratrol) and identifying sources of systemic inflammation (often gut or dental).</li>
 <li><strong>If HOMA-IR is high:</strong> Implement time-restricted feeding, strength training, and insulin sensitizers like Magnesium and Alpha-Lipoic Acid.</li>
 </ul>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is LDL-P considered a better predictor of risk than LDL-C?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">LDL-P measures the actual number of particles. A high number of particles increases the statistical probability that they will penetrate the endothelium and initiate plaque formation, regardless of how much cholesterol (weight) they carry.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What does an elevated Lp-PLA2 level signify clinically?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">It signifies "active" vascular inflammation and suggests that existing arterial plaque is unstable and more likely to rupture, leading to a cardiovascular event.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the optimal target for the Omega-3 Index?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">The optimal target is >8%. Levels below 4% are associated with significantly higher cardiovascular mortality.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does HOMA-IR help identify risk before fasting glucose?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">HOMA-IR includes fasting insulin. The body will overproduce insulin to keep glucose normal for years. By measuring insulin, we see the "effort" the body is making, revealing resistance long before the pancreas fails to keep glucose in range.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Standard lipid panels miss up to 50% of people at high risk for cardiovascular events.</li>
 <li>Particle number (LDL-P) and size (Pattern B) are superior metrics for assessing atherogenic potential.</li>
 <li>Inflammatory markers like Lp-PLA2 and MPO provide a "real-time" look at plaque stability.</li>
 <li>Metabolic profiling (HOMA-IR, Adiponectin) identifies insulin resistance up to 10 years before a Type 2 Diabetes diagnosis.</li>
 <li>Functional protocols target the specific drivers (inflammation vs. particle count vs. insulin resistance) identified in the profiling.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Otvos et al. (2011). "Low-density lipoprotein and high-density lipoprotein particle subclasses." <em>Journal of Clinical Lipidology.</em></li>
 <li>Rosenson et al. (2016). "Lipoprotein-associated phospholipase A2 and cardiovascular risk." <em>Nature Reviews Cardiology.</em></li>
 <li>Harris et al. (2018). "The Omega-3 Index and relative risk for coronary heart disease mortality." <em>Journal of Clinical Lipidology.</em></li>
 <li>Festa et al. (2000). "Insulin resistance as a predictor of cardiovascular disease." <em>Diabetes Care.</em></li>
 <li>Toth, P. P. (2014). "Lipoprotein particle number and size as markers of cardiovascular risk." <em>Current Opinion in Lipidology.</em></li>
 <li>Dullaart et al. (2021). "GlycA, a novel inflammatory marker, and its association with cardiovascular disease." <em>Clinica Chimica Acta.</em></li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}

// Standard reveal-btn logic as backup
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 // The onclick handles it above, but we keep this for consistency
 }
 });
});
</script>
</body>
</html>